Cart
sales@molnova.com
(Leu8,D-Trp22,Tyr25)-Somatostatin-28
CAS No. ———
(Leu8,D-Trp22,Tyr25)-Somatostatin-28( ——— )
Catalog No. M40425 CAS No. ———
(Leu8,D-Trp22,Tyr25)-Somatostatin-28
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Leu8,D-Trp22,Tyr25)-Somatostatin-28
-
NoteResearch use only, not for human use.
-
Brief Description(Leu8,D-Trp22,Tyr25)-Somatostatin-28
-
Description(Leu8,D-Trp22,Tyr25)-Somatostatin-28
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Clivatuzumab
Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.
-
RWJ-51204
RWJ-51204 is a selective adenosine A2A receptor antagonist and a partial agonist of GABA(A) receptor (IC50: 0.2-2 nM).
-
Denosumab
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
